Overview

Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

In the prospective monocentric open label trial patients with diabetic macular edema will be treated with intravitreal injections of ranibizumab given for 3 months then with laser grid at month 4. During follow-up a ranibizumab injection will be performed every 2 months in case of best-corrected visual acuity decreased more than 5 letters.

Phase:

Phase 2

Details

Lead Sponsor:

Poitiers University Hospital

Treatments:

Ranibizumab